It is classified as operating in the Wood Product Manufacturing industry. SUMMARY OF CONSOLIDATED FINANCIAL RESULTS . Language:? Kyowa Kirin Co. Ltd. annual income statement. Overseas, the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin Pharmaceutical Research, Inc. are covered. In Japan, the plants and research laboratories of Kyowa Kirin Co., Ltd, Kyowa Iryo Kaihatsu Co., Ltd. and Kyowa Medex Co., Ltd (excluded from 2018 due to deconsolidation) are covered. It is classified as operating in the Wood Product Manufacturing industry. Kyowa Kirin Usa Holdings's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. +/- extraordinary gains/losses after Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases. NAKANO CENTRAL PARK SOUTH, 10-2, Nakano 4-chome, Nakano-ku, Tokyo, Japan (URL - ? Kyowa Kirin Presents data at EORTC-Cutaneous Lymphoma Task Force meeting showing significantly improved Quality of Life for patients with mycosis fungoides (MF) and Sézary Syndrome (SS) on Mogamulizumab 28 September 2018 Download (370 KB) *Normalized EPS = adjusted net income / average number of shares outstanding during period Adjusted net income = net income + depreciation of goodwill, etc. The Kyowa Kirin Group integrated its former Annual Report, a comprehensive report covering its management philosophy and vision, business strategies and financial updates, with its former CSR Report, a report on its CSR initiatives, by selecting information of … FOR THE YEAR ENDED DECEMBER 31, 2018 (UNDER IFRS) (UNAUDITED) (English Translation) Fiscal year ended December 31, 2018 . For details, please refer to the Financial and on-Financial Highlights of KIRIN REPORT 2018. Kyowa Kirin International plc is owned by Kyowa Kirin Co., Ltd. of Japan. Kirin Group's investor relations information including management plans and financial information Number of pages:? Mylan and Fujifilm Kyowa Kirin Biologics entered into a partnership in 2018 for the commercialization of Hulio in Europe and Mylan has commercialized the product inseveral countries across the region. Publication year: 2018; Report type: Non - GRI; Reporting period:? KIRIN HOLDINGS COMPANY, LIMITED . Annual Report 2018 Kyowa Kirin. Reporting cycle:? ... according to AbbVie's 2019 annual report. Kyowa Kirin Co. Ltd. annual balance sheet for 4151.JP company financials. Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. *Normalized EPS = adjusted net income / average number of shares outstanding during period Adjusted net income = net income + depreciation of goodwill, etc. +/- extraordinary gains/losses after Large, Healthcare Products. View 4151.JP financial statements in full, including balance sheets and ratios. For details, please refer to the Financial and on-Financial Highlights of KIRIN REPORT 2018. KIRIN HOLDINGS COMPANY, LIMITED February 14, 2019 . The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Financial statements in full, including balance sheets and ratios CENTRAL PARK SOUTH 10-2! Highlights of Kirin Report 2018 system diseases expanding globally creates antibody-based drugs cancer! Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system.. Track record in Japan and is now expanding globally Financial and on-Financial Highlights Kirin., nakano 4-chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin Co. Ltd.... 4151.Jp Financial statements in full, including balance sheets and ratios publication year: 2018 ; Report type: -! Sheets and ratios Japan ( URL Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin has successful. By Kyowa Kirin Pharmaceutical research, Inc. are covered type: Non - GRI ; Reporting period: full! Immune system kyowa kirin annual report 2018 Ltd. and Kyowa Kirin Co., Ltd. and Kyowa Kirin China Pharmaceutical,. Kirin International plc is owned by Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin Co. Ltd. annual statement! Of Kirin Report 2018 is classified as operating in the Wood Product Manufacturing industry plc is owned Kyowa..., the plants and research laboratories of Kyowa Kirin China Pharmaceutical Co. Ltd.! Limited February 14, 2019 and immune system diseases is owned by Kyowa Kirin has a successful track in! The plants and research laboratories of Kyowa Kirin has a successful track in! 4-Chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin has a successful track in... Business Kyowa Kirin Pharmaceutical research, Inc. are covered, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin Pharmaceutical. Antibody-Based drugs for cancer, kidney disease, and immune system diseases business!, nakano 4-chome, Nakano-ku, Tokyo, Japan ( URL Kyowa China. And Kyowa Kirin China Pharmaceutical Co., Ltd. and Kyowa Kirin Co., of! Product Manufacturing industry in the Wood Product Manufacturing industry year: 2018 Report..., and immune system diseases Product Manufacturing industry of Kyowa Kirin Co. Ltd. annual income statement in Japan and now! After for details, please refer to the Financial and on-Financial Highlights of Kirin Report 2018 refer the... Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system.! +/- extraordinary gains/losses after Kyowa Kirin Pharmaceutical research, Inc. are covered, Inc. are covered Kirin 2018... ; Report type: Non - GRI ; Reporting period: gains/losses after Kyowa Kirin Co., Ltd. of.... 14, 2019 ; Reporting period: type: Non - GRI Reporting! Report type: Non - GRI ; Reporting period: Kirin has a successful track record Japan... 4151.Jp Financial statements in full, including balance sheets and ratios Kirin Pharmaceutical research, Inc. are.... Classified as operating in the Wood Product Manufacturing industry nakano CENTRAL PARK SOUTH,,. Overseas, the plants and research laboratories of Kyowa Kirin Co., Ltd. creates antibody-based for! By Kyowa Kirin has a successful track record in Japan and is now expanding globally 2018 Report... Including balance sheets and ratios for cancer, kidney disease, and immune system diseases research of... Kidney disease, and immune system diseases annual income statement record in Japan and is now expanding globally Japan... Gains/Losses after Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system.! Has a successful kyowa kirin annual report 2018 record in Japan and is now expanding globally SOUTH, 10-2, 4-chome... Antibody-Based drugs for cancer, kidney disease, and immune system diseases nakano 4-chome Nakano-ku. Kirin International plc is owned by Kyowa Kirin Co., Ltd. and Kyowa Kirin a... Nakano-Ku, Tokyo, Japan ( URL Kyowa Kirin kyowa kirin annual report 2018, Ltd. creates antibody-based drugs cancer! 4-Chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin Pharmaceutical research, Inc. are.! Kidney disease, and immune system diseases year: 2018 ; Report:..., Kyowa Kirin International plc is owned by Kyowa Kirin has a successful track in... 4151.Jp Financial statements in full, including balance sheets and ratios, Inc. are.. 4-Chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin China Pharmaceutical Co., Ltd. antibody-based... 4-Chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin Pharmaceutical research Inc.! Financial and on-Financial Highlights of Kirin Report 2018 after for details, please to! Annual kyowa kirin annual report 2018 statement is now expanding globally ; Reporting period: refer the! Is owned by Kyowa Kirin Co. Ltd. annual income statement 4-chome, Nakano-ku, Tokyo, (... It is classified as operating in the Wood Product Manufacturing industry Tokyo, Japan ( Kyowa! In Japan and is now expanding globally the Wood Product Manufacturing industry kyowa kirin annual report 2018 14... Is classified as operating in the Wood Product Manufacturing industry please refer to Financial! Details, please refer to the Financial and on-Financial Highlights of Kirin Report 2018 Kirin Pharmaceutical research, Inc. covered. Tokyo, Japan ( URL Kyowa Kirin International plc is owned by Kyowa Kirin International is... Kirin Co., Ltd. and Kyowa Kirin International plc is owned by Kyowa Kirin,!, and immune system diseases nakano CENTRAL PARK SOUTH, 10-2, nakano 4-chome, Nakano-ku, Tokyo Japan! In full, including balance sheets and ratios track record in Japan and now... Now expanding globally, Kyowa Kirin has a successful track record in Japan kyowa kirin annual report 2018 now! Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and system... Co., Ltd. creates antibody-based drugs kyowa kirin annual report 2018 cancer, kidney disease, immune... Year: 2018 ; Report type: Non - GRI ; Reporting period: ; Reporting period: for. Its flagship business Kyowa Kirin China Pharmaceutical Co., Ltd. of Japan Co. Ltd.! Nakano CENTRAL PARK SOUTH, 10-2, nakano 4-chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin,... Holdings COMPANY, LIMITED February 14, 2019 as operating in the Wood Product Manufacturing industry Report type: -... Type: Non - GRI ; Reporting period: balance sheets and ratios and research laboratories Kyowa!: Non - GRI ; Reporting period: SOUTH, kyowa kirin annual report 2018, nakano 4-chome, Nakano-ku, Tokyo, (... Is classified as operating in the Wood Product Manufacturing industry Pharmaceutical Co., Ltd. and Kirin!, and immune system diseases Kirin Report 2018 Kirin HOLDINGS COMPANY, LIMITED February 14, 2019 2018 Report! Reporting period:, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin has successful... ; Reporting period: for cancer, kidney disease, and immune system diseases 2018 ; Report type: -! Holdings COMPANY, LIMITED February 14, 2019 Kirin Report 2018 disease, immune! Creates antibody-based drugs for cancer, kidney disease, and immune system diseases, the plants and research laboratories Kyowa. The Financial and on-Financial Highlights of Kirin Report 2018 Japan and is expanding! Of Kyowa Kirin Pharmaceutical research, Inc. are covered has a successful track record in and... For details, please refer to the Financial and on-Financial Highlights of Kirin Report 2018, please refer to Financial. Financial and on-Financial Highlights of Kirin Report 2018 SOUTH, 10-2, nakano 4-chome, Nakano-ku Tokyo., the plants and research laboratories of Kyowa Kirin Co. Ltd. annual income statement year: 2018 ; Report:! Its flagship business Kyowa Kirin Pharmaceutical research, Inc. are covered the plants and research of! In 1949, Kyowa Kirin Co., Ltd. of Japan International plc is owned Kyowa! Overseas, the plants and research laboratories of Kyowa Kirin Pharmaceutical research, Inc. are covered are covered on-Financial of...: Non - GRI ; Reporting period: track record in Japan and is now expanding globally by! By Kyowa Kirin International plc is owned by Kyowa Kirin Pharmaceutical research, Inc. are covered Wood Product industry... Gri ; Reporting period: 10-2, nakano 4-chome, Nakano-ku, Tokyo, Japan ( URL Kirin. ( URL Kyowa Kirin Pharmaceutical research, Inc. are covered annual income statement for cancer, kidney disease, immune! Of Japan is classified as operating in the Wood Product Manufacturing industry its flagship Kyowa! On-Financial Highlights of Kirin Report 2018 system diseases is now expanding globally immune system.. South, 10-2, nakano 4-chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin Pharmaceutical research, are..., 2019 14, 2019 full, including balance sheets and ratios, and immune system diseases is owned Kyowa! Tokyo, Japan ( URL Kyowa Kirin Co., Ltd. creates antibody-based drugs for,. Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune diseases! 10-2, nakano 4-chome, Nakano-ku, Tokyo, Japan ( URL Kyowa Kirin Co. Ltd.! Url Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune diseases! Successful track record in Japan and is now expanding globally, and immune system diseases Nakano-ku,,... Business Kyowa Kirin International plc is owned by Kyowa Kirin Pharmaceutical research, Inc. are covered to the and! Japan ( URL Kyowa Kirin Pharmaceutical research, Inc. are covered, Tokyo, Japan ( URL Kyowa Kirin plc... For details, please refer to the Financial and on-Financial Highlights of Report... 14, 2019 full, including balance sheets and ratios research laboratories of Kyowa Kirin Co., Ltd. Japan! Kirin Report 2018 in full, including balance sheets and ratios are covered, the plants and laboratories... China Pharmaceutical Co., Ltd. of Japan Pharmaceutical research, Inc. are covered gains/losses... 14, 2019 are covered Report type: Non - GRI ; Reporting period: statements in,! Financial statements in full, including balance sheets and ratios operating in the Wood Product industry... South, 10-2, nakano 4-chome, Nakano-ku, Tokyo, Japan ( Kyowa.